Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.40 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19025083 | 0.83 | HSD17B10 (0.48) | HSD17B10CA12CA1CA2CA7 | |
| SCHEMBL1607208 | 0.82 | HSD17B10 (0.52) | HSD17B10CA12CA1CA2CA7 | |
| SCHEMBL8738071 | 0.81 | HSD17B10 (0.56) | HSD17B10CA12CA1CA2CA7 | |
| SCHEMBL875816 | 0.79 | TYR (0.61) | HSD17B10CA12CA1CA2CA7 | |
| SCHEMBL19289759 | 0.79 | HSD17B10 (0.45) | HSD17B10CA12CA1CA2CA7 | |
| Benzene SCHEMBL631929 | 0.79 | HSD17B10 (0.45) | HSD17B10CA12CA1CA2CA7 | |
| Tetrabuthylammonium SCHEMBL29130205 | 0.79 | TYR (0.39) | HSD17B10KDM4EALDH1A1L3MBTL1MEN1 | |
| SCHEMBL6131843 | 0.79 | HSD17B10 (0.54) | HSD17B10CA12CA1CA2CA7 | |
| SCHEMBL696050 | 0.79 | HSD17B10 (0.54) | HSD17B10CA12CA1CA2CA7 | |
| SCHEMBL1724358 | 0.78 | TYR (0.48) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 708 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119326738-A | Application of 4-chloro-3-ethylphenol in preparation of medicines for preventing or treating ulcerative colitis and sepsis | 青岛大学 | 2025-01-21 | — | — | CN | claimed |
| CN-118169963-A | Fluorine-free positive photosensitive polyimide resin composition | 万华化学集团股份有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-113712945-B | Application of 4-chloro-3-ethylphenol in preparation of tumor chemotherapy drug sensitizer and anti-tumor composition | 中国人民解放军陆军军医大学第二附属医院 | 2022-08-02 | — | — | CN | claimed |
| CN-113712945-A | Application of 4-chloro-3-ethylphenol in preparation of tumor chemotherapy drug sensitizer and anti-tumor composition | 中国人民解放军陆军军医大学第二附属医院 | 2021-11-30 | — | — | CN | claimed |
| US-20180311207-A1 | Novel Methods of Treating Hearing Loss | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-11-01 | — | — | US | claimed |
| EP-3368037-A1 | NOVEL METHODS OF TREATING HEARING LOSS | The Regents of The University of California (US) | 2018-09-05 | — | — | EP | claimed |
| US-10035033-B2 | Fire extinguishing composition comprising alcohol phenol compound and derivative thereof | XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD. (CN) | 2018-07-31 | — | — | US | claimed |
| WO-2017074830-A1 | NOVEL METHODS OF TREATING HEARING LOSS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-05-04 | — | — | WO | claimed |
| EP-3095487-A1 | FIRE EXTINGUISHING COMPOSITION COMPRISING ALDOKETONES COMPOUND | Xi'an J&R Fire Fighting Equipment Co., Ltd. (CN) | 2016-11-23 | — | — | EP | claimed |
| EP-3095486-A2 | FIRE EXTINGUISHING COMPOSITION COMPRISING ALCOHOL PHENOL COMPOUND AND DERIVATIVE THEREOF | Xi'an J&R Fire Fighting Equipment Co., Ltd. (CN) | 2016-11-23 | — | — | EP | claimed |
| WO-2001068605-A1 | POLYCYCLIC ARYL AND HETEROARYL SUBSTITUTED BENZENES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2001-09-20 | — | — | WO | claimed |
| US-20010018446-A1 | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. (US) | 2001-08-30 | — | — | US | claimed |
| EP-1115695-A1 | (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(N+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Monsanto Company (US) | 2001-07-18 | — | — | EP | claimed |
| EP-1115693-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Monsanto Company (US) | 2001-07-18 | — | — | EP | claimed |
| EP-1115694-A1 | SUBSTITUTED N-ALIPHATIC-N-AROMATIC (TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Monsanto Company (US) | 2001-07-18 | — | — | EP | claimed |
| WO-2000018724-A1 | (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | MONSANTO COMPANY (US) | 2000-04-06 | — | — | WO | claimed |
| WO-2000018723-A1 | SUBSTITUTED N-ALIPHATIC-N-AROMATIC TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | MONSANTO COMPANY (US) | 2000-04-06 | — | — | WO | claimed |
| WO-2000018721-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | MONSANTO COMPANY (US) | 2000-04-06 | — | — | WO | claimed |
| WO-1998030900-A2 | SCREENING METHOD FOR COMPOUNDS ACTIVE IN TREATING MYOPIA AND HYPERMETROPIA | KLAUS TRIER APS (DK) | 1998-07-16 | — | — | WO | claimed |
| US-5136109-A | PROCESS FOR PREPARING 2,4-DICHLORO-3-ALKYL-6-NITROPHENOLS | TAOKA CHEMICAL COMPANY, LTD. (JP) | 1992-08-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010018446-A1 | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | CETP, DBI, MTTP | HSD17B10 422/4885CA12 4852/4885CA1 4814/4885 |
| US-20180311207-A1 | Novel Methods of Treating Hearing Loss | ATP2A1, ATP2A2, ATP2A3 | HSD17B10 3518/4885CA12 2974/4885CA1 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.